Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SIGNIFOR safely and effectively. See full prescribing information for SIGNIFOR. SIGNIFOR ® (pasireotide) injection, for subcutaneous use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
SIGNIFOR is indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.
- generic_name
- pasireotide
- product_names
- pasireotide
- ndc
- 55292-131, 55292-132, 55292-133, 55292-131-01, 55292-131-06, 55292-131-60, 55292-132-01, 55292-132-06, 55292-132-60, 55292-133-01, 55292-133-06, 55292-133-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en